Aspire Biopharma Holdings Inc (ASBP) concluded trading on Thursday at a closing price of $0.31, with 53.47 million shares of worth about $16.58 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -97.65% during that period and on June 26, 2025 the price saw a gain of about 27.71%. Currently the company’s common shares owned by public are about 48.90M shares, out of which, 39.39M shares are available for trading.
Stock saw a price change of -3.74% in past 5 days and over the past one month there was a price change of 28.84%. Year-to-date (YTD), ASBP shares are showing a performance of -97.18% which decreased to -97.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.22 but also hit the highest price of $15.80 during that period. The average intraday trading volume for Aspire Biopharma Holdings Inc shares is 12.35 million. The stock is currently trading -15.13% below its 20-day simple moving average (SMA20), while that difference is down -18.20% for SMA50 and it goes to -95.45% lower than SMA200.
Aspire Biopharma Holdings Inc (NASDAQ: ASBP) currently have 48.90M outstanding shares and institutions hold larger chunk of about 2.90% of that.
The stock has a current market capitalization of $15.16M and its 3Y-monthly beta is at 0.81. It has posted earnings per share of -$1.71 in the same period. It has Quick Ratio of 0.22. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ASBP, volatility over the week remained 12.70% while standing at 20.79% over the month.
